Literature DB >> 8132804

Audit of deaths from cervical cancer: proposal for an essential component of the National Screening Programme.

D N Slater1, P C Milner, H Radley.   

Abstract

AIMS: To ascertain the type and relative frequency of major factors associated with deaths from cervical cancer.
METHODS: Deaths from cervical cancer in Rotherham district for the period 1989-1991 were subjected to multifactorial audit by reviewing laboratory, hospital, and general practitioner records; together with, when appropriate, re-screening of cytology smears. This period represented the three to five years after a computerised National Screening Programme (NSP) had been implemented with a five year recall interval.
RESULTS: Thirty six deaths were identified. The average age of death was 59 years with 39% occurring in those over 65. Only 6% of cases presented as a result of a cervical smear, comprising 3% derived from the NSP and 3% by chance. Forty seven per cent of cases in which the patient had died had no record of a previous smear invitation; 22% of patients were under 65 years and 25% 65 or over. Those under 65 had presented before the appropriate age band had been called. A non-response to a cervical smear invitation was identified in 22%. In 25% of cases a true negative smear had been reported one to eight years previously (average 4.8 years). An inappropriate laboratory diagnosis was identified in 17% of cases. Fourteen per cent represented false negative smears and 8% comprised inadequate smears that had been reported as negative. Inappropriate clinical diagnosis or management was identified in 19% of cases. In 22% two or more contributory factors were identified in the same patient.
CONCLUSIONS: Areas highlighted by the audit warranting further attention included the targeting of women over 65 with no cytology record; those not responding to smear invitations; laboratory performance; clinical acumen; and the reasons for true negative cervical smears. Multifactorial audit of all deaths from cervical cancer should be advocated nationally to assess and improve the effectiveness of the NSP.

Entities:  

Mesh:

Year:  1994        PMID: 8132804      PMCID: PMC501751          DOI: 10.1136/jcp.47.1.27

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

Review 1.  Screening for cancer of the cervix in elderly women.

Authors:  A Fletcher
Journal:  Lancet       Date:  1990-01-13       Impact factor: 79.321

2.  Investigation of non-responders at a cervical cancer screening clinic in Manchester.

Authors:  V Nathoo
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-09

3.  An audit of cervical cancer deaths in Nottingham.

Authors:  S H Wilson; J Johnson
Journal:  Cytopathology       Date:  1992       Impact factor: 2.073

4.  Cervical smear histories of 500 women with invasive cervical cancer in Yorkshire.

Authors:  M E Paterson; K R Peel; C A Joslin
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-06

5.  Are patients with abnormal cervical smears adequately managed?

Authors:  J M Elwood; R E Cotton; J Johnson; G M Jones; J Curnow; M W Beaver
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-06

6.  Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s.

Authors:  H Mitchell; G Medley; G Giles
Journal:  BMJ       Date:  1990-06-23
  6 in total
  9 in total

1.  Neither one-time negative screening tests nor negative colposcopy provides absolute reassurance against cervical cancer.

Authors:  Philip E Castle; Ana C Rodríguez; Robert D Burk; Rolando Herrero; Allan Hildesheim; Diane Solomon; Mark E Sherman; Jose Jeronimo; Mario Alfaro; Jorge Morales; Diego Guillén; Martha L Hutchinson; Sholom Wacholder; Mark Schiffman
Journal:  Int J Cancer       Date:  2009-10-01       Impact factor: 7.396

Review 2.  Cost-effective policies for cervical cancer screening. An international review.

Authors:  M C Fahs; S B Plichta; J S Mandelblatt
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

3.  Multifactorial audit of invasive cervical cancer.

Authors:  A Rubin
Journal:  J Clin Pathol       Date:  1995-08       Impact factor: 3.411

4.  Cervical cytology external and internal quality assurance: a comparative appraisal.

Authors:  D N Slater
Journal:  J Clin Pathol       Date:  1995-02       Impact factor: 3.411

5.  Audit of deaths from cervical cancer.

Authors:  J A Harvey
Journal:  J Clin Pathol       Date:  1994-09       Impact factor: 3.411

6.  [Reevaluation of cytological smears in patients with cervical cancer. Regional quality assurance program with the cooperation of the Austrian Society for Cytology, the Carinthian Medical Association and the Carinthian Ministry of Health].

Authors:  P Regitnig; H P Dinges; E Ropp; H Fladerer; F Moinfar; G Breitenecker
Journal:  Pathologe       Date:  2007-09       Impact factor: 1.011

7.  Multifactorial audit of invasive cervical cancer: key lessons for the National Screening Programme.

Authors:  D N Slater
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

8.  Primary screening for cervical cancer precursors by the combined use of liquid-based cytology, computer-assisted cytology and HPV DNA testing.

Authors:  P Vassilakos; P Petignat; M Boulvain; A Campana
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

9.  Impact of screening on cervical cancer incidence: A population-based case-control study in the United States.

Authors:  Rebecca Landy; Peter D Sasieni; Christopher Mathews; Charles L Wiggins; Michael Robertson; Yolanda J McDonald; Daniel W Goldberg; Isabel C Scarinci; Jack Cuzick; Cosette M Wheeler
Journal:  Int J Cancer       Date:  2019-12-31       Impact factor: 7.316

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.